IS THERE ANY DIFFERENCE IN RA PATIENTS FOR METHOTREXATE USE VS. LEFLUNOMIDE USE AS A CONCOMITANT TREATMENT WITH BIOLOGICAL AND TARGETED SYNTHETIC DMARDS IN TURKBIO REGISTRY?
Author
Karatas, A.
Yalcinkaya, YASEMİN
Can, G.
Pehlivan, Y.
Tufan, A.
YAZICI, AYTEN
ÇEFLE, AYŞE
Akar, S.
Senel, S.
Oz, B.
AKKOC, N.
Onen, F.
Inanc, N.
Ozen, G.
Dalkilic, E.
Koca, S. S.
Metadata
Show full item recordCollections
- Bildiri [64839]